Literature DB >> 11777953

Peptide specificity of thymic selection of CD4+CD25+ T cells.

Rafal Pacholczyk1, Piotr Kraj, Leszek Ignatowicz.   

Abstract

The CD4(+)CD25(+) regulatory T cells can be found in the thymus, but their need to undergo positive and negative selection has been questioned. Instead, it has been hypothesized that CD4(+)CD25(+) cells mature following TCR binding to MHC backbone, to low abundant MHC/peptide complexes, or to class II MHC loaded with peripheral autoantigens. In all these circumstances, processes that are distinct from positive and negative selection would govern the provenance of CD4(+)CD25(+) cells in the thymus. By comparing the development of CD4(+)CD25(-) and CD4(+)CD25(+) cells in mice expressing class II MHC molecules bound with one or many peptide(s), we show that the CD4(+)CD25(+) cells appear during natural selection of CD4(+) T cells. The proportion of CD4(+)CD25(+) cells in the population of CD4(+) thymocytes remains constant, and their total number reflects the complexity of selecting class II MHC/peptide complexes. Hence, thymic development of CD4(+)CD25(+) cells does not exclusively depend on the low-density, high-affinity MHC/peptide complexes or thymic presentation of peripheral self-Ags, but, rather, these cells are selected as a portion of the natural repertoire of CD4(+) T cells. Furthermore, while resistant to deletion mediated by endogenous superantigen(s), these cells were negatively selected on class II MHC/peptide complexes. We postulate that while the CD4(+)CD25(+) thymocytes are first detectable in the thymic medulla, their functional commitment occurs in the thymic cortex.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11777953     DOI: 10.4049/jimmunol.168.2.613

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  26 in total

Review 1.  CD4+ CD25+ Treg: divide and rule?

Authors:  Lucy S K Walker
Journal:  Immunology       Date:  2004-02       Impact factor: 7.397

2.  An MHC-linked locus modulates thymic differentiation of CD4+CD25+Foxp3+ regulatory T lymphocytes.

Authors:  Julie Tellier; Joost P M van Meerwijk; Paola Romagnoli
Journal:  Int Immunol       Date:  2006-08-30       Impact factor: 4.823

3.  Molecular signature of recent thymic selection events on effector and regulatory CD4+ T lymphocytes.

Authors:  Paola Romagnoli; Denis Hudrisier; Joost P M van Meerwijk
Journal:  J Immunol       Date:  2005-11-01       Impact factor: 5.422

4.  Agonist ligands expressed by thymic epithelium enhance positive selection of regulatory T lymphocytes from precursors with a normally diverse TCR repertoire.

Authors:  Julie Ribot; Paola Romagnoli; Joost P M van Meerwijk
Journal:  J Immunol       Date:  2006-07-15       Impact factor: 5.422

Review 5.  The development and function of regulatory T cells.

Authors:  Creg J Workman; Andrea L Szymczak-Workman; Lauren W Collison; Meenu R Pillai; Dario A A Vignali
Journal:  Cell Mol Life Sci       Date:  2009-04-24       Impact factor: 9.261

Review 6.  The T-cell receptor repertoire of regulatory T cells.

Authors:  Rafal Pacholczyk; Joanna Kern
Journal:  Immunology       Date:  2008-12       Impact factor: 7.397

7.  Nonself-antigens are the cognate specificities of Foxp3+ regulatory T cells.

Authors:  Rafal Pacholczyk; Joanna Kern; Nagendra Singh; Makio Iwashima; Piotr Kraj; Leszek Ignatowicz
Journal:  Immunity       Date:  2007-09       Impact factor: 31.745

8.  Genetic control of thymic development of CD4+CD25+FoxP3+ regulatory T lymphocytes.

Authors:  Paola Romagnoli; Julie Tellier; Joost P M van Meerwijk
Journal:  Eur J Immunol       Date:  2005-12       Impact factor: 5.532

9.  Shaping of the autoreactive regulatory T cell repertoire by thymic cortical positive selection.

Authors:  Julie Ribot; Geneviève Enault; Sylvie Pilipenko; Anne Huchenq; Maryline Calise; Denis Hudrisier; Paola Romagnoli; Joost P M van Meerwijk
Journal:  J Immunol       Date:  2007-11-15       Impact factor: 5.422

10.  Anti-CD4-mediated selection of Treg in vitro - in vitro suppression does not predict in vivo capacity to prevent graft rejection.

Authors:  Vanessa Oliveira; Birgit Sawitzki; Stephanie Chapman; Christine Appelt; Inga Gebuhr; Joanna Wieckiewicz; Elaine Long; Kathryn J Wood
Journal:  Eur J Immunol       Date:  2008-06       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.